findmyKOL
Clinical trialNCT01281631CompletedPhase 2Interventional

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

SponsorNeuraltus Pharmaceuticals, Inc.Enrollment136Amyotrophic Lateral Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Robert G. Miller, MD

    Forbes Norris ALS Treatment and Research, California Pacific Medical Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic, Scottsdale

    Scottsdale, Arizona, United States

  • Uc, Irvine

    Irvine, California, United States

  • Ucla

    Los Angeles, California, United States

  • California Pacific Med Center Forbes Norris Mda/als Research and Treatment Center

    San Francisco, California, United States

  • Mayo Clinic, Jacksonville

    Jacksonville, Florida, United States

  • the Emory Clinic

    Atlanta, Georgia, United States

  • University of Kansas Medical Center, Landon Center on Aging

    Kansas City, Kansas, United States

  • University of Kentucky, Department of Neurology

    Lexington, Kentucky, United States

  • Massachusetts General Hospital

    Charlestown, Massachusetts, United States

  • Columbia University

    New York, New York, United States

  • Suny Upstate Medical University, Syracuse

    Syracuse, New York, United States

  • Carolinas Medical Center

    Charlotte, North Carolina, United States

  • Duke University, Dept of Neurology

    Durham, North Carolina, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Providence Als Center

    Portland, Oregon, United States

  • Methodist Hospital Research Institute, Methodist Neurologic Institute

    Houston, Texas, United States

  • Providence Saint Peter Hospital

    Centralia, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2011
Primary completion
30 Sept 2012
Completion
30 Sept 2012
Last update posted
22 Nov 2012
Registered enrollment
136
Registry id
NCT01281631

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.